Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
160.00
+10.50 (7.02%)
At close: Feb 11, 2026

TPE:6919 Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Feb '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
248,00094,36523,5407,528--
Market Cap Growth
161.53%300.87%212.69%---
Enterprise Value
241,48884,68522,6946,297--
Last Close Price
160.0061.5019.136.11--
PS Ratio
7087.732123.71604.64587.23--
PB Ratio
26.459.736.296.47--
P/TBV Ratio
26.459.736.296.47--
EV/Sales Ratio
-1905.86582.91491.18--
Debt / Equity Ratio
0.000.000.010.030.062.81
Net Debt / Equity Ratio
-0.69-1.00-0.99-0.93-0.870.80
Net Debt / EBITDA Ratio
9.4013.887.483.582.60-0.39
Net Debt / FCF Ratio
15.5118.148.534.214.44-0.75
Asset Turnover
0.000.010.020.010.030.05
Inventory Turnover
2.657.045.992.252.412.89
Quick Ratio
112.80183.4250.4823.0415.001.45
Current Ratio
114.40184.0250.8123.4115.261.72
Return on Equity (ROE)
-5.11%-8.76%-19.92%-31.64%-64.89%-528.22%
Return on Assets (ROA)
-4.64%-6.59%-12.68%-20.53%-30.68%-33.22%
Return on Capital Employed (ROCE)
-7.60%-7.40%-13.70%-27.00%-34.30%-64.90%
Earnings Yield
-0.20%-0.62%-2.08%-3.80%--
FCF Yield
-0.17%-0.56%-1.84%-3.41%--
Buyback Yield / Dilution
-13.14%-15.40%-5.77%-27.35%-23.49%-6.52%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.